HEALIUS LIMITED — Call Transcript 2024

Sep 22, 2024

ASX Announcement (ASX: HLS)

ASX Limited Market Announcements Office Exchange Centre Level 4, 20 Bridge Street Sydney NSW 2000

==> picture [138 x 28] intentionally omitted <==

ACN 064 530 516 REGISTERED OFFICE: LEVEL 22 161 Castlereagh Street SYDNEY NSW 2000 TEL: +61 2 9432 9400 FAX: +61 2 9432 9447

23 September 2024

Investor Call – Sale of Lumus Imaging to Affinity Equity Partners

Conference call details are as follows:

Date: 23 September 2024 Time: 10.30 AM (AEST)

• • Pre-Registration Link: https://s1.c conf.com/diamondpass/10042266 ugeer.html

You will receive a calendar invite, phone number and a unique code which is to be quoted when dialling into the call.

To ask a question, participants will need to dial “*1” (star, 1) on their telephone keypad.

ENDS

The release of this announcement has been authorised by the Company Secretary.

For further information contact: Amy Liu 0466 023 858

For over 30 years Healius has been one of Australia’s leading healthcare companies, committed to supporting quality, affordable and accessible healthcare for all Australians. Today, Healius has two core diagnostics businesses, pathology and imaging. Through its unique footprint of centres and its 10,500 employees, Healius provides Australia-wide specialty diagnostic services to consumers and their referring practitioners.